Inventor · disambiguated record
Peter Fey
Also filed as: FEY PETER
85 granted patents·7 pending applications·1,664 citations·filing 1988–2024
99Inventor score
Top patents by PatentIndex Score
92 records- 0198US8802847B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesBAYER IP GMBH·Filed 2012·Granted Aug 12, 2014·21 cites·2 claims
- 0298US5177080ASubstituted pyridyl-dihydroxy-heptenoic acid and its saltsBAYER AG·Filed 1991·Granted Jan 5, 1993·401 cites·9 claims
- 0398US5006530ACertain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseasesBAYER AG·Filed 1989·Granted Apr 9, 1991·279 cites·19 claims
- 0495US9150573B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesBAYER IP GMBH·Filed 2014·Granted Oct 6, 2015·8 cites·3 claims
- 0595US5356911ASubstituted biphenylpyridonesBAYER AG·Filed 1992·Granted Oct 18, 1994·60 cites·4 claims
- 0693US9604948B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2015·Granted Mar 28, 2017·5 cites·8 claims
- 0793US5169857A7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosisBAYER AG·Filed 1990·Granted Dec 8, 1992·62 cites·9 claims
- 0891US5032602AInhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thionesBAYER AG·Filed 1989·Granted Jul 16, 1991·64 cites·17 claims
- 0990US9845300B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2017·Granted Dec 19, 2017·3 cites·1 claims
- 1089US5407948ASubstituted mono- and bipyridylmethylpyridonesBAYER AG·Filed 1994·Granted Apr 18, 1995·78 cites·10 claims
- 1188US5395840AHeterocyclically substituted phenyl-cyclohexane-carboxylic acid derivativesBAYER AG·Filed 1994·Granted Mar 7, 1995·37 cites·10 claims
- 1287US6235908B1Method for producing (S,S)-benzyl-2,8-diazabicyclo[4.3.0]nonaneBAYER AG·Filed 1999·Granted May 22, 2001·37 cites·20 claims
- 1386US5401746ASubstituted pyridines heptenoic acid derivatives, useful for treating arterioscleros, lipopotaemia and the likeBAYER AG·Filed 1992·Granted Mar 28, 1995·26 cites·5 claims
- 1484US5407942ABiphenylmethyl-substituted pyridonesBAYER AG·Filed 1993·Granted Apr 18, 1995·28 cites·8 claims
- 1584US5254543ASulphonylbenzyl-substituted pyridones which are angiotension II receptor antagonistsBAYER AG·Filed 1993·Granted Oct 19, 1993·55 cites·7 claims
- 1684US5120782ASubstituted pyrrolo-pyridines pharmaceuticalsBAYER AG·Filed 1991·Granted Jun 9, 1992·59 cites·12 claims
- 1782US6566523B1Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonaneBAYER AG·Filed 2000·Granted May 20, 2003·11 cites·10 claims
- 1880US10633356B2Hydrates of substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·12 claims
- 1979US5952498AProcess for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido 1,2a! indolcarboxcyclic acids and their activated derivativesBAYER AG·Filed 1997·Granted Sep 14, 1999·24 cites·10 claims
- 2077US12202805B2Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 2177US5861385ASubstituted triolsBAYER AG·Filed 1993·Granted Jan 19, 1999·17 cites·8 claims
- 2277US5594010ASubstituted monopyridylmethyl derivativesBAYER AG·Filed 1994·Granted Jan 14, 1997·18 cites·7 claims
- 2377US5418243ASubstituted 4-phenyl-pyridones and 4-phenyl-3-alkoxypyridinesBAYER AG·Filed 1993·Granted May 23, 1995·38 cites·8 claims
- 2475US5414008AImidazolyl-substituted phenylpropionic and cinnamic acid derivativesBAYER AG·Filed 1993·Granted May 9, 1995·15 cites·8 claims
- 2574US6277833B1Substituted triolsBAYER AG·Filed 1998·Granted Aug 21, 2001·13 cites·16 claims
- 2674US5863930ATrisubstituted biphenylsBAYER AG·Filed 1995·Granted Jan 26, 1999·14 cites·15 claims
- 2772US12138256B2Treatment of cardiopulmonary disordersBAYER AG·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 2871US10633357B2Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·3 claims
- 2971US6774236B1Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivativesBAYER AG·Filed 1999·Granted Aug 10, 2004·16 cites·2 claims
- 3071US5354749ASulfonylbenzyl-substituted benzo- and pyridopyridonesBAYER AG·Filed 1993·Granted Oct 11, 1994·27 cites·7 claims
- 3171US2025263381A1Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2024·Application pending·0 cites
- 3271US2022234996A1Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical IngredientBayer Pharma AG·Filed 2022·Application pending·0 cites
- 3369US10364229B2Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparingADVERIO PHARMA GMBH·Filed 2017·Granted Jul 30, 2019·0 cites·3 claims
- 3469US2025090519A1Treatment of cardiopulmonary disordersBAYER AG·Filed 2024·Application pending·0 cites
- 3567US5145959ASubstituted pyrido (2,3-d) pyrimidines as intermediatesBAYER AG·Filed 1991·Granted Sep 8, 1992·9 cites·3 claims
- 3665US6987185B2Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine-carboxylate-recemateBAYER HEALTHCARE AG·Filed 2002·Granted Jan 17, 2006·1 cites·5 claims
- 3763US11332435B2Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredientBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·1 claims
- 3863US5599823ASubstituted biphenylpyridonesBAYER AG·Filed 1994·Granted Feb 4, 1997·13 cites·25 claims
- 3961US5470982ADisubstituted pyridinesBAYER AG·Filed 1992·Granted Nov 28, 1995·5 cites·1 claims
- 4061US5164506ASubstituted 2-pyridones and pyrid-2-thiones compoundsBAYER AG·Filed 1991·Granted Nov 17, 1992·9 cites·2 claims
- 4161US5137881ASubstituted pyrido-oxazine inhibitors of hmg-coa reductaseBAYER AG·Filed 1991·Granted Aug 11, 1992·9 cites·10 claims
- 4260US4968681ASubstituted hydroxylaminesBAYER AG·Filed 1988·Granted Nov 6, 1990·8 cites·5 claims
- 4359US5627285ASulphonylbenzyl-substituted imidazolylpropenoic acid derivativesBAYER AG·Filed 1995·Granted May 6, 1997·6 cites·3 claims
- 4459US5527809ASubstituted imidazo[4,5-b]pyridines and benzimidazolesBAYER AG·Filed 1994·Granted Jun 18, 1996·14 cites·7 claims
- 4559US5034399ASubstituted 1,8-naphthyridines and their use in medicamentsBAYER AG·Filed 1990·Granted Jul 23, 1991·15 cites·9 claims
- 4658US5459156AImidazolyl-substituted phenylacetic acid prolinamidesBAYER AG·Filed 1994·Granted Oct 17, 1995·13 cites·12 claims
- 4758US5352687ASubstituted phenylacetamidesBAYER AG·Filed 1993·Granted Oct 4, 1994·13 cites·6 claims
- 4857US4988711AHMG-CoA reductare-inhibiting N-substituted N-amino-pyrrolesBAYER AG·Filed 1989·Granted Jan 29, 1991·8 cites·11 claims
- 4956US5576342APhenylglycinamides of heterocyclically substitued phenylacetic acid derivativesBAYER AG·Filed 1994·Granted Nov 19, 1996·5 cites·9 claims
- 5056US5376671APropenoyl-imidazole derivativesBAYER AG·Filed 1993·Granted Dec 27, 1994·5 cites·11 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Fey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →